Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
285.51 USD   -0.15%
12/03Amgen says experimental obesity drug has promising durability
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on AMGEN INC.
11/18Credit Suisse Starts Amgen at Underperform With $240 PT, Says Recent Performance Not Re..
MT
11/18Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy,..
MS
11/09DA Davidson Adjusts Amgen Price Target to $310 From $275, Maintains Buy Rating
MT
11/08Oppenheimer Adjusts Amgen Price Target to $300 From $290, Maintains Outperform Rating
MT
11/07UBS Adjusts Amgen Price Target to $271 From $257, Maintains Neutral Rating
MT
11/04Morgan Stanley Adjusts Price Target on Amgen to $282 From $279, Maintains Overweight Ra..
MT
11/04Piper Sandler Boosts Price Target on Amgen to $278 From $265, Reiterates Overweight Rat..
MT
11/04RBC Boosts Price Target on Amgen to $240 From $235, Maintains Sector Perform Rating
MT
11/04Morgan Stanley Boosts Price Target on Amgen to $282 From $279, Calls Q3 'Solid,' Mainta..
MT
11/03Analyst recommendations: Amazon, BP, Cognizant, Hiscox, Estee La..
MS
10/31Barclays Downgrades Amgen to Underweight From Equalweight, Price Target is $234
MT
10/21UBS Adjusts Amgen's Price Target to $257 From $248, Maintains Neutral Rating
MT
10/12Barclays Adjusts Amgen's Price Target to $234 from $236, Maintains Equalweight Rating
MT
10/11Morgan Stanley Raises Amgen to Overweight From Equalweight, Price Target to $279 From $..
MT
10/06RBC Trims Price Target on Amgen to $235 From $236, Maintains Sector Perform Rating
MT
08/09Atlantic Equities Adjusts Amgen's Price Target to $182 from $190, Keeps Underweight Rat..
MT
08/08UBS Adjusts Amgen Price Target to $248 From $242, Maintains Neutral Rating
MT
08/05RBC Raises Price Target on Amgen to $236 From $224, Cites 'Another Quarter of Solid Exe..
MT
08/05Morgan Stanley Raises Price Target on Amgen to $257 From $253, Highlights 'Solid Beat' ..
MT
08/05Piper Sandler Adjusts Amgen's Price Target to $265 From $260, Reiterates Overweight Rat..
MT
07/15Analyst recommendations: Adobe, Amgen, Cisco, Dollar General, Mi..
MS
07/14Morgan Stanley Adjusts Price Target for Amgen to $253 From $239, Maintains Equalweight ..
MT
07/07RBC Lifts Price Target on Amgen to $224 From $223, Maintains Sector Perform Rating
MT
06/01Oppenheimer Raises Amgen's Price Target to $290 From $285, Maintains Outperform Rating
MT
05/23SVB Securities Initiates Amgen at Market Perform With $256 Price Target
MT
05/23Analyst recommandations: AbbVie, Amgen, Caterpillar, HP, Nike...
MS
05/10Mizuho Securities Lifts Amgen's Price Target to $208 From $202, Citing Repatha Peak Rev..
MT
04/28Goldman Sachs Adjusts Price Target for Amgen to $291 From $287, Maintains Buy Rating
MT
04/28BMO Capital Adjusts Amgen's Price Target to $243 from $263, Keeps Market Perform Rating
MT
04/28UBS Adjusts Amgen Price Target to $245 From $251, Maintains Neutral Rating
MT
04/28RBC Lifts Price Target on Amgen to $223 From $218, Maintains Sector Perform Rating
MT
04/28Piper Sandler Adjusts Amgen's Price Target to $260 From $255, Reiterates Overweight Rat..
MT
04/27UBS Adjusts Amgen Price Target to $251 From $235, Maintains Neutral Rating
MT
04/12Morgan Stanley Adjusts Amgen's Price Target to $237 from $238, Keeps Equalweight Rating
MT
04/12Barclays Adjusts Price Target for Amgen to $236 From $233, Maintains Equalweight Rating
MT
02/10UBS Adjusts Amgen Price Target to $235 From $232, Maintains Neutral Rating
MT
02/09Jefferies Adjusts Amgen's Price Target to $280 From $266, Reiterates Buy Rating
MT
02/09Oppenheimer Adjusts Amgen's Price Target to $285 From $272, Maintains Outperform Rating
MT
02/09Wells Fargo Adjusts Amgen's Price Target to $250 From $210, Keeps Equalweight Rating
MT
02/09Morgan Stanley Raises Price Target on Amgen to $238 From $235, Maintains Equalweight Ra..
MT
02/09Barclays Adjusts Amgen's Price Target to $233 From $228, Keeps Equalweight Rating
MT
02/08UBS Adjusts Amgen's Price Target to $232 From $227, Maintains Neutral Rating
MT
01/05BofA Securities Downgrades Amgen to Neutral from Buy, Adjusts Price Target to $255 from..
MT
2021RBC Lifts Price Target on Amgen to $218 From $216, Citing Tezspire's Approval in Severe..
MT
2021Wells Fargo Starts Amgen at Equalweight With $210 Price Target
MT
2021Goldman Sachs Starts Amgen at Buy With $258 Price Target
MT
2021Analyst recommendations: Activision Blizzard, Amgen, Ebay, Vmwar..
MS
2021Mizuho Securities Cuts Amgen's Price Target to $194 From $222, Citing 'Potential 2022 H..
MT
2021BMO Capital Starts Amgen at Market Perform With $228 Price Target
MT
2021Barclays Adjusts Price Target on Amgen to $228 From $230, Maintains Equal-Weight Rating
MT
2021UBS Lowers Amgen's Price Target to $223 From $246, Maintains Neutral Rating
MT
2021SVB Leerink Adjusts Price Target on Amgen to $216 From $234, Keeps Market Perform Ratin..
MT
2021Oppenheimer Adjusts Amgen's Price Target to $272 From $277, Maintains Outperform Rating
MT
2021Amgen : Morgan Stanley Adjusts Amgen PT $235 from $251, Keeps Equalweight Rating
MT
2021Amgen : Daiwa Securities Downgrades Amgen to Neutral From Outperform, Price Target..
MT
2021Analyst recommendations: Amgen, Apple, AstraZeneca, FedEx, T-Mob..
MS
2021Amgen : Morgan Stanley Downgrades Amgen to Equalweight from Overweight, Adjusts Pr..
MT
2021Analyst recommendations: Amgen, Banner, Merck, Oracle, Phoenix....
MS
2021Amgen : Mizuho Securities Lifts Amgen's Price Target to $222 From $200, Citing Lum..
MT
2021Amgen : SVB Leerink Adjusts Amgen's Price Target to $234 from $238, Keeps Market P..
MT
2021Amgen : Morgan Stanley Adjusts Price Target on Amgen to $280 From $278, Maintains ..
MT
2021Analyst recommendations: Amgen, Biogen, Halfords, J Sainsbury, U..
MS
2021Amgen : Oppenheimer Adjusts Amgen's Price Target to $277 from $272, Keeps Outperfo..
MT
2021Amgen : SVB Leerink Adjusts Amgen's Price Target to $238 from $230, Keeps Market P..
MT
2021Amgen : Oppenheimer Adjusts Amgen PT to $270 From $265, Maintains Outperform Ratin..
MT
2021Amgen : Oppenheimer Adjusts Amgen PT to $265 From $275, Maintains Outperform Ratin..
MT
2021Amgen : UBS Adjusts Amgen's Price Target to $238 From $250, Citing Sotorasib Dosin..
MT
2021Amgen : Goldman Sachs Adjusts Amgen's Price Target to $290 From $281, Maintains Bu..
MT
2021Amgen : Morgan Stanley Adjusts Amgen's Price Target to $278 From $281, Maintains O..
MT
2021Amgen : JPMorgan Adjusts Amgen's Price Target to $215 From $222, Maintains Neutral..
MT
2021Amgen : Atlantic Equities Downgrades Amgen to Underweight From Neutral, Keeps $200..
MT
2021Amgen : Piper Sandler Adjusts Amgen's Price Target to $255 From $260, Maintains Ov..
MT
2021Amgen : Credit Suisse Raises Amgen's PT to $259 from $265 on Lower-than-Consensus ..
MT
2021Amgen : RBC Cuts Price Target on Amgen to $217 From $220, Reiterates Sector Perfor..
MT
2021AMGEN INC : Goldman Sachs maintains a Buy rating
MD
1  2Next